Progress in the Development of Nonpeptidomimetic BACE 1 Inhibitors for Alzheimer's Disease

E-ISSN： 1875-533x|16|14|1806-1820

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.14, 2009-05, pp. : 1806-1820

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of BACE1 Inhibitors for Alzheimer's Disease

Current Medicinal Chemistry, Vol. 13, Iss. 15, 2006-06 ,pp. : 1811-1829

Bentham Science Publishers

Access to resources Recommend Favorite

Dual BACE-1/GSK-3β Inhibitors to Combat Alzheimer's Disease: A Focused Review

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 31, 2018-02 ,pp. : 3361-3369

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Discovery of BACE Inhibitors

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-01 ,pp. : 3383-3404

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in the drug discovery of non-peptidic BACE1 inhibitors

By Hamada Yoshio Kiso Yoshiaki

Expert Opinion on Drug Discovery, Vol. 4, Iss. 4, 2009-04 ,pp. : 391-416

Informa Healthcare

Access to resources Recommend Favorite

Progress in acetylcholinesterase inhibitors for Alzheimer's disease: an update

By Tumiatti Vincenzo Bolognesi Maria Laura Minarini Anna Rosini Michela Milelli Andrea Matera Riccardo Melchiorre Carlo

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 4, 2008-04 ,pp. : 387-401

Informa Healthcare

Access to resources Recommend Favorite